Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jian Liu, M.D
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - JinYu Xia, M.Med
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Lei Luo
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Li Ding, M.D
Fifth Affiliated Hospital, Sun Yat-Sen University
Study Director - Lisi Deng, M.Med
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Minyi Lin, M.Med
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Xi Liu, M.D
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Xiaoqing Luo
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Yayi Huang
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Yin Li
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Yuanli Chen, M.Med
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Zhongsi Hong, M.Med
Fifth Affiliated Hospital, Sun Yat-Sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Fifth Affiliated Hospital Sun Yat-Sen University
Zhuhai, Guangdong, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2020
- Primary completion
- 1 Feb 2023
- Completion
- 1 Feb 2024
- Last update posted
- 5 Dec 2019
- Registered enrollment
- 286
- Registry id
- NCT04187469
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.